Help
RSS
API
Feed
Maltego
Contact
Domain > perspective.bakku.website
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2025-02-01
94.130.146.202
(
ClassC
)
Port 443
HTTP/1.1 200 OKcache-control: max-age0, private, must-revalidatecontent-length: 10777content-type: text/html; charsetutf-8cross-origin-window-policy: denydate: Sat, 01 Feb 2025 17:07:38 GMTx-download-options: noopenx-permitted-cross-domain-policies: nonex-request-id: GCAkkH-evURz6XAAAHzBx-xss-protection: 1; modeblockset-cookie: _itbmed_keySFMyNTY.g3QAAAABbQAAAAtfY3NyZl90b2tlbm0AAAAYSmJkS3RLZldmWVNHSGZxNXlxaVZ3UFlE.5sb_PgoV3eW1UAZig6YEk8pSZhPoQ45EMoAzx7uk0nQ; path/; HttpOnlystrict-transport-security: max-age63072000x-content-type-options: nosniffreferrer-policy: strict-originx-frame-options: SAMEORIGINcontent-security-policy: default-src https: wss: data: blob: unsafe-inline unsafe-eval; frame-ancestors https://*.bakku.cloudpermissions-policy: autoplay*, picture-in-picture* !DOCTYPE html>html langen> head> meta charsetutf-8> meta http-equivX-UA-Compatible contentIEedge> meta nameviewport contentwidthdevice-width, initial-scale1.0>meta contentABAXGTcCLT4HPjEeADYDYgACPG8dGghzJrsRCIKiagbYHPrWysU9jJQ7 namecsrf-token>title data-suffixITB-MED - Perspective> ITB-MED - Perspective/title>meta contentITB-MED - Perspective propertyog:site_name> link phx-track-static relstylesheet href/assets/app-6e5464de3c4448fe684ec396b992d3a2.css?vsnd> script phx-track-static typetext/javascript src/js/mapbox-gl-3527badffc97c73709930dce19c9bcd9.js?vsnd>/script> script phx-track-static typetext/javascript src/js/mapbox-gl-geocoder.min-a79f69a43d3a3af88c884bdef7bfd772.js?vsnd>/script> script phx-track-static typetext/javascript src/js/turf.min-9b592d24b14c224d86bf44b90ad29945.js?vsnd>/script> script defer phx-track-static typetext/javascript src/assets/app-e343accd8fe081192a453bbb15f820ab.js?vsnd>/script> link relapple-touch-icon sizes180x180 href/images/favicon/apple-touch-icon.png> link relicon typeimage/png sizes32x32 href/images/favicon/favicon-32x32.png> link relicon typeimage/png sizes16x16 href/images/favicon/favicon-16x16.png> link relmanifest href/images/favicon/site.webmanifest> /head> body> div classlandscape-block> div classphone> div classcircle-rotate> div classno>/div> div classyes>/div> /div> /div> div classtext>Please rotate your screen/div> /div>div data-phx-main data-phx-sessionSFMyNTY.g2gDaAJhBXQAAAAIdwJpZG0AAAAUcGh4LUdDQWtrSC1pWHZMcGNIMEJ3B3Nlc3Npb250AAAAAHcEdmlld3cdRWxpeGlyLkl0Ym1lZFdlYi5Eb2N1bWVudExpdmV3CnBhcmVudF9waWR3A25pbHcGcm91dGVydxdFbGl4aXIuSXRibWVkV2ViLlJvdXRlcncIcm9vdF9waWR3A25pbHcMbGl2ZV9zZXNzaW9uaAJ3B2RlZmF1bHRuCAAbuSQ1_ljjF3cJcm9vdF92aWV3dx1FbGl4aXIuSXRibWVkV2ViLkRvY3VtZW50TGl2ZW4GAE14e8KUAWIAAVGA.cgYup4a3vNYJtIfEfnEfvEnaf2qUpCijvTFrFx2mfm4 data-phx-staticSFMyNTY.g2gDaAJhBXQAAAADdwJpZG0AAAAUcGh4LUdDQWtrSC1pWHZMcGNIMEJ3BWZsYXNodAAAAAB3CmFzc2lnbl9uZXdqbgYATXh7wpQBYgABUYA.72sHZ4xw9i4mMTatrpLM7-_TIBZ2dM2s2pfQO8L1cOU idphx-GCAkkH-iXvLpcH0B>div classheader idheader phx-hookDarkHeader> div classwrapper> a classlogo data-phx-linkredirect data-phx-link-statepush href/> img classlight src/images/logo-white.svg> img classdark src/images/logo.svg> /a> ul classnav> li> a classactive data-phx-linkredirect data-phx-link-statepush href/home>Home/a> /li> li> a data-phx-linkredirect data-phx-link-statepush href/about>About/a> /li> li> a data-phx-linkredirect data-phx-link-statepush href/eligibility>Eligibility/a> /li> /ul> button typebutton aria-labelToggle Navigation classmobile-nav-btn phx-click"dispatch",{"to":null,"event":"nav:toggle"}> span classlines>/span> /button> /div>/div>main classcontent> section classblock top-block> div classbg bg-parallax idparallax phx-hookParallax> div data-depth0.17> img srchttps://static.bakku.website/55f84581-da03-4ede-9fec-71d3a8bef92a/56a785c7-66a1-4ae8-ab08-adfbd6239370.jpg?nearlossless1 altPerspective.01jpg.jpg> /div> div data-depth0.33> img srchttps://static.bakku.website/55f84581-da03-4ede-9fec-71d3a8bef92a/9276915e-1734-49e9-a7a4-26f2e420538a.png?nearlossless1 altPerspective_02-2.png> /div> div data-depth0.5> img srchttps://static.bakku.website/55f84581-da03-4ede-9fec-71d3a8bef92a/97b272a9-be75-4584-a46d-1a00e986b5eb.png?nearlossless1 altPerspective_03-2.png> /div> div data-depth0.67> img srchttps://static.bakku.website/55f84581-da03-4ede-9fec-71d3a8bef92a/084cb285-5d1e-48d5-8b1d-4d4f162fe0f7.png?nearlossless1 altPerspective_04-2.png> /div> div data-depth0.83> img srchttps://static.bakku.website/55f84581-da03-4ede-9fec-71d3a8bef92a/84baa687-9bac-45ef-a1d3-c1705010b2cb.png?nearlossless1 altPerspective_05-2.png> /div> div data-depth1.0> img srchttps://static.bakku.website/55f84581-da03-4ede-9fec-71d3a8bef92a/12afcad4-8a86-4df1-bd27-31834f026966.png?nearlossless1 altPerspective_06-3.png> /div> div classbottom-gradient data-depth1.10>/div> /div> div classwrapper> div classrow> div classcol size1of1> div classtext> h1>New horizons in kidney transplantation/h1> p>Immune tolerance/p> /div> /div> /div> div classintro-small> p classql-align-center>Kidney transplant recipients normally take anti-rejection drugs to help protect the transplanted kidney. The study will use a new approach to see if patients can reduce or stop anti-rejection drugs.span stylecolor: rgb(255, 255, 255);>br>/span>/p> /div> /div>/section> section classblock col2> div classwrapper> div classrow> div classcol size1of2> div classtext> h2>What is Immune Tolerance?/h2> p classql-align-justify>Immune tolerance means a transplant patient can keep their kidney without taking anti-rejection drugs./p>p classql-align-justify>These drugs prevent rejection but can have serious side effects such as infections, heart problems, tremors, cancer and reduced function in the transplanted kidney./p>p classql-align-justify>The Perspective Study is evaluating an experimental treatment approach that could eliminate the need for anti-rejection drugs for living donor kidney transplant recipients. For more information click below./p> a href https://perspective.itb-med.com/about target_blank relnoopener classbtn>About Perspective/a> /div> /div> div classcol size1of2> div classtext> h2>Study now enrolling patients/h2> p classql-align-justify>If you are a kidney failure patient who can receive a kidney transplant from a living donor, you may be eligible to participate in the Perspective Study./p>p classql-align-justify>This website provides you with an overview of the study and important information for transplant recipients and their living donors./p>p classql-align-justify>For more information, please click below to reach the eligibility page and answer three short questions./p> a hrefhttps://perspective.itb-med.com/eligibility target_blank relnoopener classbtn>Study Eligibility/a> /div> /div> /div> /div>/section> section classblock image-slider idslides-11582391> div classslides> div classslide active stylebackground-image:url(https://static.bakku.website/55f84581-da03-4ede-9fec-71d3a8bef92a/395e92e1-6531-4df1-bdf3-c6f1f494e0c3.jpg?nearlossless1);>/div> /div> /section>/main>div classpopup contactform idcontact-form-modal> div classpopup-content> div classinner> div classform> button typebutton classclose phx-clickclose phx-target#contact-form-modal>span classicon icon-delete>/span>/button> h2>Your information/h2> form methodpost idc-form-modal phx-changevalidate phx-submitsend phx-target7> div classfield phx-feedback-forcontact_formname> input idc-form-modal_name namecontact_formname phx-debounce200 placeholderName: typetext> /div> div classfield phx-feedback-forcontact_formemail> input idc-form-modal_email namecontact_formemail phx-debounce200 placeholderEmail: typetext> /div> div classfield phx-feedback-forcontact_formphone> input idc-form-modal_phone namecontact_formphone phx-debounce200 placeholderPhone: typetext> /div> div classfield phx-feedback-forcontact_formstate> input idc-form-modal_state namecontact_formstate phx-debounce200 placeholderState: typetext> /div> div classfield phx-feedback-forcontact_formcountry> input idc-form-modal_country namecontact_formcountry phx-debounce200 placeholderCountry: typetext> /div> div classfield phx-feedback-forcontact_formmessage> textarea idc-form-modal_message namecontact_formmessage phx-debounce200 placeholderMessage:>/textarea> /div> div classfield> button phx-disable-withSending... typesubmit> Send message span classicon icon-arrow-long-right>/span> /button> /div> /form> /div> /div> /div>/div>section classfooter> div classtop> div classwrapper> div classrow> div classcol size1of4> div classlogo> img src/images/logo-white.svg> /div> /div> div classcol size1of4> ul> li>US Office/li> li>ITB-MED LLC/li> li>110 East 59th St FL 28/li> li>New York, NY 10022/li> li>United States/li> /ul> /div> div classcol size1of4> ul> li>Swedish Office/li> li>ITB-MED AB/li> li>Hagaplan 4/li> li>113 68 Stockholm/li> li>Sweden/li> /ul> /div> div classcol size1of4> ul> li>Contact us/li> li>a hrefhttps://itb-med.com relnoopener external target_blank>ITB-MED/a>/li> li>a hrefhttps://www.linkedin.com/company/itbmed/>LinkedIn/a>/li> /ul> /div> /div> /div> /div> div classbottom> div classwrapper> ul classnav> li>© ITB-MED 2025/li> /ul> div classcredits> website by a hrefhttps://sensu.org/ target_blank>Sensu/a> /div> /div> /div>/section>/div> /body>/html>
Subdomains
Date
Domain
IP
ascend.bakku.website
2025-01-21
94.130.146.202
perspective.bakku.website
2025-02-01
94.130.146.202
mijnkantoor.bakku.website
2024-10-23
94.130.146.202
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]